Conditions: Major Depressive Disorder
Keywords: Major Depressive Disorder Long-term Safety Open-label
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 74
Healthy volunteers: no

Brief summary:
The purpose of the study is to evaluate long-term safety and tolerability of Vortioxetine over a period of 52 weeks in patients with Major Depressive Disorder (MDD) having completed 6-week acute treatment in study NCT00839423 / 11492A.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Vortioxetine (Lu AA21004)
Intervention descriptions: intervention 1: 5 or 10 mg/day; tablets; orally

Protocol document: